Citations

Clear

16280 citation(s) found for "Yu, David".

Symptom Patterns in Adults With Cyclic Vomiting Syndrome: A 6‐Month Prospective Observational Study
Chen, Yaozhu J. , Rodriguez, Danielle , Richmond, Camilla A., Levinthal, David J. , Li, B U.K. , Petrakis, Ioannis , Coyne, Karin S. , Wu, Melody , Tack, Jan , Hasler, William L. , Levinthal, David J , Li, B U K , Venkatesan, Thangam , Tack, Jan , Rodriguez, Danielle, Venkatesan, Thangam

Mayo Clinic

Neurogastroenterology & Motility | December 31, 2024 | Volume: 37 | Issue: 2 | Pages: No page available

10.1111/nmo.14974 | PMID 39737520 Get It

ABSTRACTBackgroundData are limited on the natural history and symptom patterns of cyclic vomiting syndrome (CVS), a disorder of gut–brain interaction characterized by recurrent stereotypical vomiting, retching, and nausea episodes.MethodsA 6‐month, observational, remote study prospectively assessed symptom patterns in adults with CVS using an electronic daily diary. Patients recorded their disease experience, including CVS symptoms and associated severity, in the daily diary. The study defined a CVS episode start as the first day of 5 or more vomiting and/or retching (V + R) events. Episode end was defined as the first day of ≥ 7 (prespecified main analysis) or ≥ 4 (sensitivity analysis) days without any diary V + R events.Key ResultsEighty‐eight of 93 (94.6%) enrolled patients (62 female; mean age, 37.7 years) had daily diary data recorded during the study; 61 (69.3%) patients had at least one episode. In the prespecified main analysis, 191 episodes (median, 0.6 per 30 diary days) were reported (median duration, 3.0 days); 17.8% of the episodes lasted > 10 days. In the sensitivity analysis, 248 episodes (median, 0.7 per 30 diary days) were reported (median duration, 2.0 days). Thirteen of 88 (14.8%) patients with diary data had interepisodic V + R (reported V + R events without meeting the threshold for study‐defined episode). Other CVS‐related (non‐V + R) symptoms (most frequently nausea, abdominal pain, and sweating) were reported more frequently during the episode versus the interepisodic period.Conclusions and InferencesThis prospective longitudinal study shows marked heterogeneity of CVS episodes and highlights the need to better define and characterize episodes in these patients.
Real‐Time 2D Phase‐Contrast MRI to Assess Cardiac‐ and Respiratory‐Driven CSF Movement in Normal Pressure Hydrocephalus
Karki, Pragalv , Murphy, Matthew C. , Ganji, Sandeep , Gunter, Jeffrey L. , Graff‐Radford, Jonathan, Cutsforth‐Gregory, Jeremy K. , Elder, Benjamin D. , Jack, Clifford R. , Jack, Clifford R , Ganji, Sandeep K , Graff‐Radford, Jonathan , Jones, David T. , Botha, Hugo , Huston, John , Cogswell, Petrice M.

Mayo Clinic

Journal of Neuroimaging | December 31, 2024 | Volume: 35 | Issue: 1 | Pages: No page available

10.1111/jon.70000 | PMID 39737803 Get It

ABSTRACT Background and Purpose In idiopathic normal pressure hydrocephalus (iNPH) patients, cerebrospinal fluid (CSF) flow is typically evaluated with a cardiac‐gated two‐dimensional (2D) phase‐contrast (PC) MRI through the cerebral aqueduct. This approach is limited by the evaluation of a single location and does not account for respiration effects on flow. In this study, we quantified the cardiac and respiratory contributions to CSF movement at multiple intracranial locations using a real‐time 2D PC‐MRI and evaluated the diagnostic value of CSF dynamics biomarkers in classifying iNPH patients. Methods This study included 37 participants: 16 iNPH, 10 Alzheimer's disease (AD), and 11 cognitively unimpaired (CU) controls. Anatomical and real‐time (non‐gated) PC images were acquired in a 3T Philips scanner. CSF flow was assessed at the foramen magnum, fourth ventricle, Sylvian fissure, lateral ventricle, and cerebral aqueduct. We calculated three CSF dynamics biomarkers: mean velocity amplitude, cardiac signal power, and respiratory signal power. Biomarkers from each location were evaluated for classifying iNPH versus AD and CU using support vector machine (SVM). A p ‐value of 0.05 or less was considered statistically significant. Results The velocity amplitude and cardiac signal power were significantly reduced in iNPH compared to CU ( p < 0.005) and AD ( p < 0.05) at the lateral ventricle. The SVM model using biomarkers from the lateral ventricle performed significantly better at classifying iNPH than the other locations in terms of accuracy ( p < 0.005) and diagnostic odds ratio ( p < 0.05). Conclusion Evaluation of CSF movement beyond the cerebral aqueduct may aid in identifying patients with and understanding the pathophysiology of iNPH.
Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children’s Oncology Group Bone Tumor Committee Consensus Statement
Dietz, Matthew S. , Al‐Ibraheemi, Alyaa , Craig, Brian T. , Dasgupta, Roshni, Geller, David S. , Shulman, David S. , Whiteway, Susan L. , Slotkin, Emily K. , Albert, Catherine M. , Montgomery, Nicole I. , Sandberg, Jesse K. , Grier, Holcombe E. , Krailo, Mark , Isakoff, Michael S. , Rubin, Elyssa, Lawlor, Elizabeth R. , DuBois, Steven G. , Grohar, Patrick J. , Janeway, Katherine A. , Roberts, Ryan D. , Dasgupta, Roshni , Ahmed, Safia K. , Dasgupta, Roshni , Roberts, Ryan D , Davis, Jessica L. , Hawkins, C. Matthew , Cohen‐Gogo, Sarah , Gupta, Ajay Kumar , Heske, Christine M. , Indelicato, Daniel J. , Mascarenhas, Leo , Binitie, Odion , Reed, Damon R. , Bailey, Kelly M.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | December 27, 2024 | Volume: 23 | Issue: 1 | Pages: No page available

10.6004/jnccn.2024.7063 | PMID 39729709 Get It

Trends in diagnostic biopsy sample collection approaches for primary bone sarcomas have shifted in the past 2 decades. Although open/incisional biopsies used to be the predominant approach to obtain diagnostic material for Ewing sarcoma and osteosarcoma, image-guided core needle biopsies have increased in frequency and are safe for patients. These procedures are less invasive and reduce recovery times but have potential limitations. The quantity and quality of tissue obtained through these procedures vary between institutions. Acquired viable tissue volumes can be low, limiting the conduct of downstream expanded clinical workup, molecular analyses, and research. Patients with advanced Ewing sarcoma and osteosarcoma continue to have overall poor outcomes despite dose-intensive cytotoxic chemotherapy. The biology of treatment resistance is not currently well understood, partly due to limited availability of relevant tissue to study. There is a need for access to quality tumor specimens for molecular and other analyses to identify high-risk tumor subsets and drive discovery to improve patient outcomes. Given broad variability in bone tumor tissue procurement and processing across member institutions, the Children’s Oncology Group Bone Tumor Committee convened a multidisciplinary group of experts to outline the current and near-future tissue needs for optimal clinical care and access to research platforms. The goal of this working group was to provide high-level guidance on biopsy practices that safely meet these evolving needs. Harmonizing tissue collection practices is paramount to improving the care of children, adolescents, and young adults diagnosed with Ewing sarcoma and osteosarcoma.
Artificial Intelligence in Pediatric Electrocardiography: A Comprehensive Review
Leone, David M. , O’Sullivan, Donnchadh , Jaimes, Katia Bravo, Bravo-Jaimes, Katia , O'Sullivan, Donnchadh

Mayo Clinic

Children | December 27, 2024 | Volume: 12 | Issue: 1 | Pages: 25

10.3390/children12010025 | PMID 39857856 Get It

Artificial intelligence (AI) is revolutionizing healthcare by offering innovative solutions for diagnosis, treatment, and patient management. Only recently has the field of pediatric cardiology begun to explore the use of deep learning methods to analyze electrocardiogram (ECG) data, aiming to enhance diagnostic accuracy, expedite workflows, and improve patient outcomes. This review examines the current state of AI-enhanced ECG interpretation in pediatric cardiology applications, drawing insights from adult AI-ECG research given the progress in this field. It describes a broad range of AI methodologies, investigates the unique challenges inherent in pediatric ECG analysis, reviews the current state of the literature in pediatric AI-ECG, and discusses potential future directions for research and clinical practice. While AI-ECG applications have demonstrated considerable promise, widespread clinical adoption necessitates further research, rigorous validation, and careful consideration of equity, ethical, legal, and practical challenges.
Influence of Vessel Geometry, Flow Conditions, and Thrombin Concentration on Fibrin Accumulation and Cerebral Aneurysm Occlusion After Flow Diversion
Cebral, Juan R. , Mut, Fernando , Löhner, Rainald , Marsh, Laurel , Chitsaz, Alireza , Bilgin, Cem , Bayraktar, Esref Alperen , Kallmes, David F. , Kadirvel, Ramanathan , Bayraktar, Esref Alperen , Kallmes, David, Marsh, Laurel , Cebral, Juan R , Bilgin, Cem

Mayo Clinic

International Journal for Numerical Methods in Biomedical Engineering | December 26, 2024 | Volume: 41 | Issue: 1 | Pages: No page available

10.1002/cnm.3904 | PMID 39725674 Get It

ABSTRACT As the number of cerebral aneurysms treated with flow diverters continues to increase, it is important to understand what factors influence not only thrombus formation within the aneurysm cavity but also fibrin accumulation across the device and its associated disruption and blockage of the inflow stream. Both processes contribute to the eventual occlusion of the aneurysm or its continued patency and incomplete occlusion which may require future re‐treatment. To investigate fibrin accumulation on flow diverters placed across the neck of cerebral aneurysms, a previously developed computational model that couples flow and fibrin dynamics is used in combination with experimental in vitro models of cerebral aneurysms treated with flow diverters. Fibrin accumulation was previously investigated in four glass models of cerebral aneurysms with varying parent artery geometries placed in a flow loop at different flow rates. Corresponding computational models were constructed and compared with the experimental findings. The computational model based on fibrin production stimulated from flow shear stress and subsequent adhesion to device wires was able to reproduce and explain the fibrin accumulation patterns observed in the experimental aneurysms treated with flow diverters. Specifically, these models indicated that increasing vessel curvature, flow rate, and thrombin concentration induced faster fibrin accumulation and associated aneurysm inflow disruption and blockage. The models described and tested in this paper are valuable to understand the detailed mechanisms leading to aneurysm occlusion and healing or incomplete occlusions after treatment with flow diverting devices.
Neuropsychological Functioning in Cognitively Normal, Older American Indians of the Southwestern United States
Cerbone, Brittany , Hanson, Krista D., Lomay, Vicky T., Wicklund, Meredith, Weidman, David

Mayo Clinic

Archives of Clinical Neuropsychology | December 26, 2024 | Volume: 40 | Issue: 5 | Pages: 954-964

10.1093/arclin/acae116 | PMID 39724234 Get It

Abstract Objective There is a dearth of research on neuropsychological functioning and the validity of assessment measures in American Indian (AI) older adults. The present study sought to comprehensively examine neuropsychological functioning in cognitively normal AI older adults in the southwestern USA (i.e., Arizona). Participants and Methods Ninety predominantly female participants (45 AIs and 45 non-Hispanic Whites) aged 44 years and older (mean age of mid-60s) were matched on age, decade, gender, and assessment battery. Participants were enrolled in the Arizona Alzheimer’s Disease Center database. Data obtained included demographics, medical history, psychiatric variables, and raw neuropsychological scores. Analyses included ANCOVAs, chi-square, and stepwise multiple regression. Results AIs generally had lower performance across all neuropsychological measures compared with matched Whites, even after controlling for demographic variables. Performance between groups was most discrepant on several measures of global cognition, attention, executive functioning, and language, while performance was statistically comparable on measures of memory and visuospatial abilities. The AI group had higher proportions of diabetes and obesity, but results showed that higher cardiovascular risk was not predictive of lower cognitive performance with the exception of the Clinical Dementia Rating Scale–Sum of Boxes. Conclusions Findings suggest that older AIs perform lower on many neuropsychological measures compared with non-Hispanic Whites, even after controlling for demographic variables. This suggests that other factors, including language, culture, educational quality, overall health, socioeconomic status, and level of acculturation may be impacting test scores and need to be considered when assessing and diagnosing older AIs.
Impact of Patient Factors on Robotic-Assisted Partial Nephrectomy Operating Room Times: The Case for Fixed Operating Room Time as a Viable Efficiency Target
Qosja, Neda, Geldmaker, Laura , Hasse, Christopher H., Tiwari, Vartika, Fuqua, Taylor R., Haehn, Daniela A. , Thomas, Colleen S. , Hochwald, Alex, Thiel, David D.

Mayo Clinic

Journal of Endourology | December 26, 2024 | Volume: 39 | Issue: 2 | Pages: 121-126

10.1089/end.2024.0330 | PMID 39723975 Get It

Introduction: To analyze the association of patient characteristics on operating room (OR) times for robotic-assisted partial nephrectomies (RAPNs). Methods: In total, 248 consecutive RAPNs were performed by a single surgeon from October 2018 to August 2022. Data were collected on the following patient factors: sex, age, race, weight, body mass index (BMI), diabetes, hypertension (HTN), tumor side, tumor mass, and American Society of Anesthesiologists (ASA) score. Total fixed OR times were evaluated as the sum of in-room time to anesthesia-release time (IRAT), anesthesia-release time to cut time (ARCT), close time to wheels out time (CTWO), and in-room time to cut time (IRAT + ARCT). Total variable OR times were defined as cut time to close time (CTCT). Total operative time was defined as wheels into wheel out (WIWO). Results: Median OR time was 265 minutes (interquartile range [IQR]: 247–298 minutes) for WIWO, 191 minutes (IQR: 170–225 minutes) for CTCT, and 75 minutes (IQR: 68–83 minutes) for total fixed time. There was a significant increase in WIWO with the following patient variables: male sex (18.0 minutes, 95% confidence interval [CI]: 6.3–29.7 minutes), weight (5.6 minutes, 95% CI: 2.8–8.4 minutes), BMI (14.3 minutes, 95% CI: 4.2–24.4 minutes), HTN (15.1 minutes, 95% CI: 3.7–26.5 minutes), pathology tumor size (cm) (6.4 minutes, 95% CI: 2.2–10.6 minutes), and ASA score (13.8 minutes, 95% CI: 3.1–24.4 minutes). Sex, age, BMI, weight, HTN, and pathology tumor size significantly impacted CTCT ( P < 0.05). Total fixed OR time was only affected by ASA score ( P = 0.02). Conclusions: Patient variables significantly affect total OR time and variable OR time. These variables do not impact total fixed OR times, confirming fixed OR time as a viable OR efficiency point.
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors
Solomon, David A., Lukas, Rimas V. , Packer, Roger J. , Wen, Patrick Y. , Chang, Susan M. , Fouladi, Maryam , Phillips, Joanna J. , Aldape, Kenneth , Holdhoff, Matthias , Mellinghoff, Ingo K. , Arons, David, Solomon, David A. , Solomon, David A , Mellinghoff, Ingo K , Horbinski, Craig , Solomon, David A., Brastianos, Priscilla K. , Wen, Patrick Yung , Snuderl, Matija , Berger, Mitchel S. , Nabors, Burt , Brat, Daniel J. , Huse, Jason T. , Sarkaria, Jann N. , Burns, Terry C. , Peters, Katherine B. , Galanis, Evanthia

Mayo Clinic

JAMA Oncology | December 26, 2024 | Volume: 11 | Issue: 3 | Pages: 317

10.1001/jamaoncol.2024.5506 | PMID 39724142 Get It

Importance Molecular techniques, including next-generation sequencing, genomic copy number profiling, fusion transcript detection, and genomic DNA methylation arrays, are now indispensable tools for the workup of central nervous system (CNS) tumors. Yet there remains a great deal of heterogeneity in using such biomarker testing across institutions and hospital systems. This is in large part because there is a persistent reluctance among third-party payers to cover molecular testing. The objective of this Review is to describe why comprehensive molecular biomarker testing is now required for the accurate diagnosis and grading and prognostication of CNS tumors and, in so doing, to justify more widespread use by clinicians and coverage by third-party payers. Observations The 5th edition of the World Health Organization (WHO) classification system for CNS tumors incorporates specific molecular signatures into the essential diagnostic criteria for most tumor entities. Many CNS tumor types cannot be reliably diagnosed according to current WHO guidelines without molecular testing. The National Comprehensive Cancer Network also incorporates molecular testing into their guidelines for CNS tumors. Both sets of guidelines are maximally effective if they are implemented routinely for all patients with CNS tumors. Moreover, the cost of these tests is less than 5% of the overall average cost of caring for patients with CNS tumors and consistently improves management. This includes more accurate diagnosis and prognostication, clinical trial eligibility, and prediction of response to specific treatments. Each major group of CNS tumors in the WHO classification is evaluated and how molecular diagnostics enhances patient care is described. Conclusions and Relevance Routine advanced multidimensional molecular profiling is now required to provide optimal standard of care for patients with CNS tumors.
Position statement of the World Endoscopy Organization: Role of endoscopy in screening, diagnosis, and treatment of esophageal superficial squamous neoplasiaia
Hassan, Cesare , Goda, Kenichi, Iyer, Prasad G. , Awadhi, Sameer Al , Lehibi, Abed Al , Arantes, Vitor , Burgos, Herbert, Cerisoli, Cecilio L., Dawsey, Sanford, Fleischer, David, Fluxá, Fernando, Inoue, Haruhiro , John, Sneha , Khashab, Mouen A., Kothari, Shivangi , Lee, Yeong Yeh, Ngamruengphong, Saowanee , Sharara, Ala I. , Shimamura, Yuto , Varocha, Mahachai, Villa‐Gomez, Guido, Wang, Kenneth K. , Yip, Hon Chi , Sharma, Prateek , Lee, Yeong Yeh , Chiu, Philip Wai Yan , Emura, Fabian , G Iyer, Prasad, Kim, Gwang Ha , Shimamura, Yuto , Yip, Hon-Chi , Hassan, Cesare , Lee, Yeong Yeh , Antonelli, Giulio , Burgos, Herbert, Dawsey, Sanford, Draganov, Peter V. , González, Nicolás , Kashin, Sergey V. , Khashab, Mouen A. , Lee, Yeong Yeh, Remes Troche, José M , Varocha, Mahachai, Wang, Wen‐Lun

Mayo Clinic

Digestive Endoscopy | December 26, 2024 | Volume: 37 | Issue: 5 | Pages: 470-489

10.1111/den.14967 | PMID 39722219 Get It

Esophageal squamous cell carcinoma (ESCC) remains a significant global health challenge, being the sixth leading cause of cancer mortality with pronounced geographic variability. The incidence rates range from 125 per 100,000 in northern China to 1–1.5 per 100,000 in the United States, driven by environmental and lifestyle factors such as tobacco and alcohol use, dietary habits, and pollution. Major modifiable risk factors include tobacco and alcohol consumption, with a synergistic risk increase when combined. Nonmodifiable risk factors include previous diagnoses of head and neck squamous cell carcinoma (H&N SCC), achalasia, and prior radiotherapy. Prevention strategies must be tailored to specific regional burdens to efficiently allocate medical and financial resources. Gastrointestinal endoscopy is crucial in reducing ESCC burden through early detection and characterization of neoplastic changes, such as high‐grade dysplasia. Early diagnosis significantly improves survival rates, while endoscopic resection of noninvasive dysplasia can prevent ESCC onset, reducing treatment burden for advanced disease. Postresection surveillance can detect high‐risk metachronous lesions. Despite these benefits, endoscopic prevention faces challenges, including the lack of high‐level evidence supporting its efficacy, opportunity costs, the need for specialized training and techniques, and the requirement for advanced technology investments. This Position Statement from the World Endoscopy Organization (WEO) aims to address these challenges, supplying recommendations for the exploitation of endoscopic resources regarding the possible role of screening, quality, and training for the detection, characterization, resection, and surveillance of ESCC.
Antifouling Immunomodulatory Copolymer Architectures That Inhibit the Fibrosis of Implants
Jeang, William J. , Jiang, Alexis L., Bose, Suman , Collins, Evan , McMullen, Patrick , Rosenboom, Jan‐Georg , Lathwal, Sushil , Langer, Robert , Anderson, Daniel G , Wong, Bryan Matthew , Zhao, Yichao , Manan, Rajith S. , Langer, Róbert , Anderson, Daniel G.

Mayo Clinic

Advanced Materials | December 25, 2024 | Volume: 37 | Issue: 7 | Pages: No page available

10.1002/adma.202414743 | PMID 39722171 Get It

Abstract Immune reactions to medical implants often lead to encapsulation by fibrotic tissue and impaired device function. This process is thought to initiate by protein adsorption, which enables immune cells to attach and mount an inflammatory response. Previously, several antifibrotic materials have been either designed to reduce protein adsorption or discovered via high‐throughput screens (HTS) to favorably regulate inflammation. The present work introduces antifouling immunomodulatory (AIM) copolymer coatings, which combine both strategies to effectively enhance implant protection. AIM copolymers synergistically integrate zwitterionic moieties to resist protein fouling, HTS‐derived antifibrotics for immunomodulation, and silane monomers for grafting to diverse substrates including elastomers, ceramics, and metals. Interestingly, simply combining these monomers into conventional random or block copolymer architectures yielded no significant advantage over homopolymers. By contrast, an unusual polymer chain architecture — a zwitterionic block flanked by a mixed zwitterionic immunomodulatory segment — showed superior fibrosis resistance in both peritoneal and subcutaneous sites over one month in immunocompetent mice. This architecture also improved the performance of two different HTS‐derived antifibrotic monomers, suggesting that tailoring AIM architectures may broadly complement immunomodulatory chemistries and provide a versatile approach to improving implant longevity.